25,700 Shares in Avanos Medical, Inc. (NYSE:AVNS) Purchased by Y Intercept Hong Kong Ltd

Key Points

• Y Intercept Hong Kong Ltd has acquired 25,700 shares of Avanos Medical, valued at approximately $368,000, making up about 0.06% of the company's total shares.
• Avanos Medical's stock has seen a 12-month low of $11.21 and a high of $25.36, currently trading at $11.81; the company reported earnings of $0.26 per share last quarter, exceeding analysts' expectations.
• Institutional investors and hedge funds currently own 95.17% of Avanos Medical's stock, indicating significant institutional interest in the company.

Y Intercept Hong Kong Ltd bought a new stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 25,700 shares of the company's stock, valued at approximately $368,000. Y Intercept Hong Kong Ltd owned about 0.06% of Avanos Medical at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of AVNS. Easterly Investment Partners LLC purchased a new stake in shares of Avanos Medical in the 1st quarter worth about $986,000. Rice Hall James & Associates LLC lifted its holdings in Avanos Medical by 106.1% in the first quarter. Rice Hall James & Associates LLC now owns 128,059 shares of the company's stock worth $1,835,000 after buying an additional 65,930 shares during the period. Brown Advisory Inc. boosted its position in Avanos Medical by 1.4% during the 1st quarter. Brown Advisory Inc. now owns 1,931,163 shares of the company's stock valued at $27,674,000 after acquiring an additional 26,069 shares in the last quarter. Envestnet Asset Management Inc. grew its holdings in shares of Avanos Medical by 12.6% during the 1st quarter. Envestnet Asset Management Inc. now owns 144,759 shares of the company's stock worth $2,074,000 after acquiring an additional 16,192 shares during the period. Finally, Bank of New York Mellon Corp raised its position in shares of Avanos Medical by 4.2% in the 1st quarter. Bank of New York Mellon Corp now owns 329,497 shares of the company's stock worth $4,722,000 after acquiring an additional 13,258 shares in the last quarter. Institutional investors own 95.17% of the company's stock.

Avanos Medical Stock Down 1.6%

Shares of AVNS traded down $0.18 on Friday, reaching $11.00. The stock had a trading volume of 670,789 shares, compared to its average volume of 434,917. The firm has a market capitalization of $508.41 million, a price-to-earnings ratio of -1.31 and a beta of 1.12. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.56 and a current ratio of 2.57. The company has a 50-day simple moving average of $12.11 and a 200-day simple moving average of $13.60. Avanos Medical, Inc. has a 12-month low of $10.86 and a 12-month high of $25.36.

Avanos Medical (NYSE:AVNS - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.19 by $0.07. The company had revenue of $167.50 million during the quarter, compared to analysts' expectations of $161.75 million. Avanos Medical had a positive return on equity of 6.26% and a negative net margin of 55.80%. The firm's revenue for the quarter was up .8% compared to the same quarter last year. During the same quarter last year, the business posted $0.22 EPS. Sell-side analysts predict that Avanos Medical, Inc. will post 1.32 EPS for the current year.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.